Literature DB >> 7980769

Positron emission tomography imaging of the thorax.

E F Patz1, P C Goodman.   

Abstract

Positron emission tomography (PET) is just beginning to emerge as a clinically useful tool in the thorax. Imaging with FDG is used primarily to differentiate benign from malignant abnormalities, including solitary pulmonary nodules, staging bronchogenic carcinoma, and differentiating recurrent tumor from fibrosis following treatment. This article discusses the fundamental properties of PET images, techniques, and current clinical indications in the thorax.

Entities:  

Mesh:

Year:  1994        PMID: 7980769

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  4 in total

Review 1.  Native cellular fluorescence and its application to cancer prevention.

Authors:  S P Schantz; H E Savage; P Sacks; R R Alfano
Journal:  Environ Health Perspect       Date:  1997-06       Impact factor: 9.031

2.  Quercetin: a savior of alveolar barrier integrity under hypoxic microenvironment.

Authors:  Ankit Tripathi; Puja P Hazari; Anil K Mishra; Bhuvnesh Kumar; Sarada S K Sagi
Journal:  Tissue Barriers       Date:  2021-02-26

3.  Pulmonary actinomycosis mimicking lung cancer on positron emission tomography.

Authors:  Hayoung Choi; Hyun Lee; Suk Hyeon Jeong; Sang-Won Um; O Jung Kown; Hojoong Kim
Journal:  Ann Thorac Med       Date:  2017 Apr-Jun       Impact factor: 2.219

4.  Radiation dosimetry and biodistribution of (99m)Tc-ethylene dicysteine-deoxyglucose in patients with non-small-cell lung cancer.

Authors:  Naomi R Schechter; William D Erwin; David J Yang; E Edmund Kim; Reginald F Munden; Kenneth Forster; Lina C Taing; James D Cox; Homer A Macapinlac; Donald A Podoloff
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-04-25       Impact factor: 9.236

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.